Finlay Carson MSP

Galloway and West Dumfries

Finlay welcomes life changing treatment for diabetes patients

 

 

Galloway and West Dumfries MSP Finlay Carson says he is delighted NHS Dumfries and Galloway have agreed to fund life changing treatment for those living with Type 1 Diabetes.

Following continued pressure from local campaigners and the local MSP, the NHS have revealed that Flash Glucose Monitoring treatment will be funded as part of their 2018/19 budget for those who meet the criteria.

This will mean that those living with Type 1 Diabetes will be able to access technology which will enable them to stop having to prick themselves, sometimes during the night, which has been a constant source of worry for parents of children with Type 1 diabetes.

Mr Carson raised the issue recently in the Scottish Parliament with First Minister Nicola Sturgeon committing to look into the issue.

Commenting Finlay Carson MSP said: “Today’s news is a victory for campaigners locally, including Kirkcudbright pharmacist Soenaid Anderson. This is hugely welcome news and a victory for local campaigners who have been relentlessly lobbying the health board and politicians to deliver this technology for Type 1 Diabetes patients.

“This is undoubtedly life-changing treatment and will bring a massive sense of relief in particular to families with young children who have to get up during the night to prick their child to check their blood sugar levels.

“It has been a long time coming but I am glad the local health board have listened to campaigners like Soenaid Anderson in Kirkcudbright, who has pushed on an almost daily basis for the technology to be made available. The decision really is a ‘no-brainer’ with the new technology, in many cases, delivering much improved health care, and amazingly, at a lower cost to the taxpayer!

“I raised this issue with the First Minister last month and I believe that the greater awareness this technology has received has resulted in today’s very welcome decision from the health board.

“I will be continuing to liaise closely with the health board to ensure that patients who meet the criteria receive this treatment in a timely fashion.”